Influence of treatment complexity on adherence and incidence of blips in HIV/HCV coinfected patients.

@article{CalvoCidoncha2015InfluenceOT,
  title={Influence of treatment complexity on adherence and incidence of blips in HIV/HCV coinfected patients.},
  author={Elena Calvo-Cidoncha and Javier Gonz{\'a}lez-Bueno and Carmen Victoria Almeida-Gonz{\'a}lez and Ram{\'o}n Morillo-Verdugo},
  journal={Journal of managed care & specialty pharmacy},
  year={2015},
  volume={21 2},
  pages={153-7}
}
BACKGROUND The addition of antihepatitis C therapy to highly active antiretroviral treatment (HAART) in human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfected patients leads to an increase in the treatment complexity that may result in decreased adherence. Blips, defined as intermittent episodes of detectable low-level HIV viremia, may be an indication of poor adherence to HAART. OBJECTIVES To (a) determine the influence of adding anti-HCV therapy to HAART on complexity index… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Advances in the treatment of hepatitis C virus infection

  • DL Thomas
  • Top Antivir Med
  • 2012
1 Excerpt

The consensus of the Pharmacy Practice Model Summit

  • S Martin, PL Wolters, SK Calabrese
  • Am J Health Syst Pharm
  • 2011
1 Excerpt

Similar Papers

Loading similar papers…